Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 3/20 | 0.63 |
| ▸ | CA9 | Q16790 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL16581552 | 0.98 | CA1 (0.61) | CA1CA2CA9SMN1; SMN2ALDH1A1 | |
| Biphenyl SCHEMBL112616 | 0.91 | CA1 (0.54) | CA1CA2CA9SMN1; SMN2ALDH1A1 | |
| Biphenyl SCHEMBL4512369 | 0.90 | CA1 (0.53) | CA1CA2CA9SMN1; SMN2ALDH1A1 | |
| Biphenyl SCHEMBL710425 | 0.90 | CA1 (0.53) | CA1CA2CA9SMN1; SMN2ALDH1A1 | |
| SCHEMBL3842500 | 0.88 | PTPN11 (0.50) | CA1CA2CA9SMN1; SMN2CXCR2 | |
| Diphenylsulfane SCHEMBL2191112 | 0.87 | CA1 (0.50) | CA1CA2CA9SMN1; SMN2ALDH1A1 | |
| SCHEMBL576035 | 0.85 | CA2 (0.50) | CA1CA2CA9CXCR2KIF11 | |
| SCHEMBL1473787 | 0.85 | CA2 (0.46) | CA1CA2CA9ALDH1A1MAPT | |
| Tromethamine SCHEMBL5359436 | 0.84 | CA1 (0.51) | CA1CA2CA9SMN1; SMN2ALDH1A1 | |
| SCHEMBL15946067 | 0.84 | CA1 (0.46) | CA1CA2CA9SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3790985-B1 | METHODS OF SYNTHESIZING A POLYNUCLEOTIDE ARRAY USING PHOTACTIVATED AGENTS | VIBRANT HOLDINGS LLC (US) | 2026-04-15 | — | — | EP | claimed |
| CN-110903316-B | Phosphonate compound and preparation method and application thereof | 中南大学 | 2021-03-02 | — | — | CN | claimed |
| CN-110903316-A | Phosphonate compound and preparation method and application thereof | 中南大学 | 2020-03-24 | — | — | CN | claimed |
| EP-3004120-B1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | UNIV NANYANG TECH (SG) | 2018-08-29 | — | — | EP | claimed |
| CN-105658656-A | 1, 1' -spiroindane-7, 7-bisphosphine oxides as highly active supporting ligands in palladium-catalyzed asymmetric Heck reactions | 南洋理工大学 | 2016-06-08 | — | — | CN | claimed |
| US-20160136629-A1 | SPIRO-1,1'-BINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALADIUM-CATALYZED ASYMMETRIC HECK REACTION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-05-19 | — | — | US | claimed |
| CN-100595673-C | Positive type photosensitive paste composition for PDP electrode, PDP electrode prepared therefrom, and PDP comprising the PDP electrode | SAMSUNG SDI CO LTD | 2010-03-24 | — | — | CN | claimed |
| CN-1779570-A | Positive type photosensitive paste composition for PDP electrode, PDP electrode prepared therefrom, and PDP comprising the PDP electrode | SAMSUNG SDI CO LTD (KR) | 2006-05-31 | — | — | CN | claimed |
| CN-1241065-C | Photoresist composite with optical acid-generating agent containing optical free radical generating agent | HAIRYOKSA SEMICONDUCTOR CO LTD (KR) | 2006-02-08 | — | — | CN | claimed |
| CN-1221856-C | Polymer and forming method of micro pattern using the same | HYUNDAI ELECTRONICS IND (KR) | 2005-10-05 | — | — | CN | claimed |
| CN-1146602-C | Polymer and forming method of micro pattern using the same | 现代电子产业株式会社 | 2004-04-21 | — | — | CN | claimed |
| CN-1330288-A | Photoresist composite with optical acid-generating agent containing optical free radical generating agent | HAIRYOKSA SEMICONDUCTOR CO LTD (KR) | 2002-01-09 | — | — | CN | claimed |
| CN-1238344-A | Polymer and forming method of micro pattern using the same | HYUNDAI ELECTRONICS IND (KR) | 1999-12-15 | — | — | CN | claimed |
| CN-1235171-A | Polymer and forming method of micro pattern using the same | HYUNDAI ELECTRONICS IND (KR) | 1999-11-17 | — | — | CN | claimed |
| CN-116594268-A | Method for improving adhesiveness and/or developing speed of photoresist | 华中科技大学 | 2023-08-15 | — | — | CN | disclosed |
| CN-110903316-B | Phosphonate compound and preparation method and application thereof | 中南大学 | 2021-03-02 | — | — | CN | disclosed |
| CN-110903316-A | Phosphonate compound and preparation method and application thereof | 中南大学 | 2020-03-24 | — | — | CN | disclosed |
| US-5480883-A | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-01-02 | — | — | US | disclosed |
| US-5409930-A | Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1995-04-25 | — | — | US | disclosed |
| WO-1992020642-A1 | BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160136629-A1 | SPIRO-1,1'-BINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALADIUM-CATALYZED ASYMMETRIC HECK REACTION | SBK1, SIK1, PDPK1 | CA1 3165/4885CA2 2812/4885CA9 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.